Peripheral nerve membrane proteins and structural components at injection site

The term Peripheral nerve membrane proteins and structural components at injection site refers to a collective group of molecular and anatomical structures within the peripheral nervous system that are targeted by locally administered pharmacological agents. This group primarily includes voltage-gated sodium channels (e.g., Nav1.7 and Nav1.8), which are the functional targets for local anesthetics like lidocaine to inhibit action potential propagation and provide analgesia (StatPearls, 2023). Additionally, it encompasses the structural framework of the nerve, including myelin-associated proteins like Peripheral Myelin Protein 22 (PMP22) and extracellular matrix components such as hyaluronan and collagen, which maintain the nerve's mechanical integrity and blood-nerve barrier (NIH, 2022). Drugs like hyaluronidase interact with these structural components by degrading hyaluronan to increase tissue permeability and enhance the dispersion of co-administered medications. Because this target represents a complex physiological site rather than a single discrete molecule, it is associated with a wide range of biological functions and potential safety concerns, including direct neurotoxicity and Local Anesthetic Systemic Toxicity (LAST) (PubMed, 2021). Understanding these components is critical for optimizing regional anesthesia and minimizing the risk of permanent nerve injury during therapeutic injections.

Other names

Nerve membrane proteinsPeripheral nerve structural componentsLocal anesthetic target siteNerve fiber components

Inhibition of voltage-gated sodium channels to block nerve impulse conduction; enzymatic degradation of hyaluronan in the extracellular matrix to facilitate drug dispersion; inhibition of neurotransmitter release at the neuromuscular junction.